All Programs

Use the tool below to view all available Global Neurology Academy Series

Rethinking Migraine Care: Prioritizing Patient Needs and Restoring Function
Rethinking Migraine Care: Prioritizing Patient Needs and Restoring Function
Global Neurology Academy
Rethinking Migraine Care: Prioritizing Patient Needs and Restoring Function
- Ashley Baker, MSN, PMHNP
- Stephanie Nahas, MD, MSEd
The Genetics of Migraine: Advancing Diagnosis and Personalizing Treatment
The Genetics of Migraine: Advancing Diagnosis and Personalizing Treatment
Global Neurology Academy
The Genetics of Migraine: Advancing Diagnosis and Personalizing Treatment
- Ryan Quigley
- Lyn R. Griffiths
Challenging Migraine Stereotypes: Improving Patient Care Through Empathy and Insight
Challenging Migraine Stereotypes: Improving Patient Care Through Empathy and Insight
Global Neurology Academy
Challenging Migraine Stereotypes: Improving Patient Care Through Empathy and Insight
- Charles Turck, PharmD, BCPS, BCCCP
- Rashmi B. Halker Singh, M.D.
Early Ocrelizumab Intervention in RRMS: Real-World Data Reinforces a Shift in Strategy
Early Ocrelizumab Intervention in RRMS: Real-World Data Reinforces a Shift in Strategy
NeuroFrontiers
Early Ocrelizumab Intervention in RRMS: Real-World Data Reinforces a Shift in Strategy
Data Equity in Action: Largest Real-World MS Analysis Confirms Fumarate Efficacy Across Racial Groups
Data Equity in Action: Largest Real-World MS Analysis Confirms Fumarate Efficacy Across Racial Groups
NeuroFrontiers
Data Equity in Action: Largest Real-World MS Analysis Confirms Fumarate Efficacy Across Racial Groups
Cardiopulmonary Exercise Testing Sheds Light on Early Physiologic Decline in Duchenne Muscular Dystrophy
Cardiopulmonary Exercise Testing Sheds Light on Early Physiologic Decline in Duchenne Muscular Dystrophy
NeuroFrontiers
Cardiopulmonary Exercise Testing Sheds Light on Early Physiologic Decline in Duchenne Muscular Dystrophy
Treatment of a Broader Population of Patients With DMD
Treatment of a Broader Population of Patients With DMD
CME/CE
Treatment of a Broader Population of Patients With DMD
1.00 credit
- Crystal Proud, MD
- Erika Finanger, MD, MS
1.00 credit
Improving Spinal Muscular Atrophy Outcomes Through Early Intervention
Improving Spinal Muscular Atrophy Outcomes Through Early Intervention
NeuroFrontiers
Improving Spinal Muscular Atrophy Outcomes Through Early Intervention
- Charles Turck, PharmD, BCPS, BCCCP
- Leslie Hayes, MD
American Headache Society Updates on Diagnosing and Treating Migraine
American Headache Society Updates on Diagnosing and Treating Migraine
NeuroFrontiers
American Headache Society Updates on Diagnosing and Treating Migraine
- Charles Turck, PharmD, BCPS, BCCCP
- Jessica Ailani, MD, FAHS, FAAN, FANA
Tuning the Brain: Personalized Anxiety Relief with Neurofeedback-Driven Headphones
Tuning the Brain: Personalized Anxiety Relief with Neurofeedback-Driven Headphones
NeuroFrontiers
Tuning the Brain: Personalized Anxiety Relief with Neurofeedback-Driven Headphones
- John Golden
- Michael Greenberg, MD
Exploring Timing in MS Therapy: Real-World Outcomes of Fumarates
Exploring Timing in MS Therapy: Real-World Outcomes of Fumarates
NeuroFrontiers
Exploring Timing in MS Therapy: Real-World Outcomes of Fumarates
Managing MS in Older Adults: Top 5 Clinical Considerations
Managing MS in Older Adults: Top 5 Clinical Considerations
NeuroFrontiers
Managing MS in Older Adults: Top 5 Clinical Considerations
- Yinan Zhang, MD
Empowering Patients with CIDP: Education, Support, and Personalized Care Strategies
Empowering Patients with CIDP: Education, Support, and Personalized Care Strategies
Global Neurology Academy
Empowering Patients with CIDP: Education, Support, and Personalized Care Strategies
- Danielle Minetti
- Ryan Quigley
Updates from MINT: Inebilizumab Reduces Relapses and Rescue Therapy Use
Updates from MINT: Inebilizumab Reduces Relapses and Rescue Therapy Use
NeuroFrontiers
Updates from MINT: Inebilizumab Reduces Relapses and Rescue Therapy Use
- Richard Nowak, MD, MS
How Diagnostic Delays in gMG Impact Disease Severity, Outcomes, and Quality of Life
How Diagnostic Delays in gMG Impact Disease Severity, Outcomes, and Quality of Life
NeuroFrontiers
How Diagnostic Delays in gMG Impact Disease Severity, Outcomes, and Quality of Life
- John A. Morren, MD, FAAN, FAANEM
Managing MS in Women: How to Guide Patients Through Pregnancy and Menopause
Managing MS in Women: How to Guide Patients Through Pregnancy and Menopause
NeuroFrontiers
Managing MS in Women: How to Guide Patients Through Pregnancy and Menopause
- Riley Bove, MD, MMSc

All Programs

Popular

NEED HELP?

Contact us

NEED HELP?

Contact us

All Programs

Popular

Title

Share on ReachMD